NR1H4 and clostridium difficile infection: Interestingly, a recent study using a cholate-deficient mouse strain showed that the cholate-derived secondary bile acid (DCA) is dispensable for protection against CDI, and that lack of the bile acid transcriptional activator FXR, does not show differences in CDI mice.